Diarrhea Management

Introduction to Treatment Options

• The American Society of Clinical Oncology and the European Society for Medical Oncology recommend considering loperamide as the first-line pharmacologic therapy for adults with diarrhea, due to its better safety profile and efficacy compared to diphenoxylate-atropine 1
• Diphenoxylate-atropine (Lomotil) may be considered as a second-line option for treating persistent and severe non-infectious diarrhea in adults, after loperamide, with caution in patients with fever or bloody diarrhea 1

First-Line and Second-Line Therapies

• The American Gastroenterological Association recommends loperamide as the initial dose of 4 mg, followed by 2 mg after each loose stool (maximum 16 mg daily) for first-line pharmacologic therapy in adults 1
• The American College of Gastroenterology suggests considering diphenoxylate-atropine (Lomotil), octreotide, or psyllium seeds as second-line options when loperamide is ineffective 1
• The National Institute for Health and Care Excellence recommends considering hospitalization if diarrhea persists >48 hours despite antimotility agents, with a strength of evidence rated as high 1

Contraindications and Precautions

• Diphenoxylate-atropine is contraindicated in children under 2 years of age due to the risk of severe toxicity, including respiratory depression, as stated by the American Academy of Pediatrics 2
• Loperamide is contraindicated in children under 18 years of age with acute diarrhea, and in patients with fever, bloody diarrhea, suspected inflammatory diarrhea, or risk of toxic megacolon (strong recommendation, moderate-quality evidence) 3, 4
• Diphenoxylate-atropine and loperamide should be used with caution in patients with fever, bloody diarrhea, or suspected inflammatory diarrhea, as well as in neutropenic patients, due to the risk of worsening outcomes and increased bacteremia risk, with a strength of evidence rated as moderate to low 1, 2

Treatment Approach

• The World Health Organization and the European Society for Clinical Microbiology and Infectious Diseases recommend that rehydration should always be the first priority in treating diarrhea, with oral rehydration solution for mild to moderate dehydration and IV fluids for severe dehydration until pulse, perfusion, and mental status normalize 1, 4
• The following age-specific recommendations are supported by the IDSA and the American Academy of Pediatrics (moderate-quality evidence) 3, 4

• Loperamide may be given to immunocompetent adults with acute watery diarrhea as an adjunct treatment after hydration is addressed, with an initial dose of 4 mg, followed by 2 mg after each loose stool, and a maximum daily dose of 16 mg (weak recommendation, moderate-quality evidence) 5, 6, 3
• Infection control measures, including hand hygiene and appropriate food safety practices, are essential to prevent the spread of infectious diarrhea (moderate-quality evidence) 4

Pitfalls to Avoid

• Using loperamide in children with acute diarrhea, or before ruling out infectious causes with fever or bloody diarrhea, is a pitfall to avoid (strong recommendation, moderate-quality evidence) 3, 4
• Using loperamide as the primary treatment instead of focusing on rehydration first is a pitfall to avoid (moderate-quality evidence) 3
• Continuing loperamide use if symptoms worsen or if fever develops after starting treatment is a pitfall to avoid (moderate-quality evidence) 3